Physician profile
William Patrick Springhart
NPI 1760479968
$19,924.23
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $69.79 · 2021: $1,081 · 2022: $368 · 2023: $3,362 · 2024: $3,499 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,883.29 |
| Food and Beverage | $1,381.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $13,167.63 | 2021-2025 | Focal One |
| Calyxo, INC. | $5,070.48 | 2021-2025 | Cvac Aspiration System |
| Siemens Medical Solutions USA, INC. | $1,061.94 | 2021-2025 | |
| Boston Scientific Corporation | $197.96 | 2019-2021 | |
| Coloplast Corp | $166.95 | 2020-2024 | Speedicath |
| Procept Biorobotics Corporation | $137.44 | 2025 | |
| Janssen Biotech, INC. | $36.40 | 2023 | Erleada |
| Janssen Scientific Affairs, LLC | $19.23 | 2019 | |
| Astellas Pharma US INC | $19.08 | 2025 | Xtandi |
| Urogen Pharma, INC. | $17.12 | 2025 | |
| Angiodynamics, INC. | $15.72 | 2025 | Nanoknife |
| Bayer Healthcare Pharmaceuticals INC. | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Springhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.